MARSHALL WACE, LLP - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 93 filers reported holding CYTOSORBENTS CORP in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q4 2021$31,000
-76.5%
7,627
-56.3%
0.00%
-100.0%
Q2 2021$132,000
+300.0%
17,458
+333.7%
0.00%
Q4 2018$33,0004,0250.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 964,141$7,829,0001.90%
Skylands Capital, LLC 1,837,541$14,921,0001.84%
CM Management, LLC 175,000$1,421,0001.06%
Soleus Capital Management, L.P. 800,000$6,496,0001.01%
Avenir Corp 1,395,385$11,331,0000.95%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,502,0000.55%
Winning Points Advisors, LLC 86,200$701,0000.51%
Granahan Investment Management 1,154,561$9,375,0000.18%
SECTORAL ASSET MANAGEMENT INC 244,660$1,987,0000.16%
Redmile Group, LLC 1,044,434$8,481,0000.15%
View complete list of CYTOSORBENTS CORP shareholders